Chika Ifeanyi Chukwuma1, Motlalepula G Matsabisa2, Mohammed Auwal Ibrahim3, Ochuko L Erukainure4, Matimbha H Chabalala5, Md Shahidul Islam4. 1. Department of Pharmacology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa. Electronic address: ChukwumaCI@ufs.ac.za. 2. Department of Pharmacology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa. Electronic address: MatsabisaMG@ufs.ac.za. 3. Department of Biochemistry, Ahmadu Bello University, Zaria, Nigeria. 4. Biomedical Research Laboratory, Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Durban 4000, South Africa. 5. Department of Pharmacology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Diabetes and hypertension are pathophysiologically related diseases that co-exist with a wider complex of metabolic diseases having similar set of risk factors. There are numerous ethnopharmacological evidences on the anti-diabetic and/or anti-hypertensive properties of medicinal plants from various parts of the world, which are used as therapies to concomitantly manage diabetes and hypertension. AIM OF THE REVIEW: This article reviewed findings on medicinal plants with both anti-diabetic and anti-hypertensive effects reported in same experimental study to facilitate the development of dual-acting therapies against diabetes and hypertension. MATERIALS AND METHODS: A literature search was carried out on different scientific search engines including, but not limited to "PubMed", "Google Scholar", "Scopus" and ScienceDirect to identify published data in which plants in same experimental studies were reported to possess both anti-hyperglycemic and anti-hypertensive effects. Subsequently, the anti-diabetic/anti-hypertensive potency ratio (ψ) of the medicinal plants was computed. RESULTS: Sixty-four studies with 102 plant species matched the selection criteria. Members of the Fabaceae family were the most investigated plants, while the ψ greatly varied across the plants, with only 11 plants having a ψ ≃ 1. Withania somnifera Dunal was the only plant reported to show blood glucose-lowering and diuretic effects in humans, comparable to daonil. Caffeic acid, chlorogenic acid, caftaric acid, cichoric acid, verbascoside, leucosceptoside A, isoacteoside, fucoxanthin and nicotinamide were the reported dual acting anti-diabetic and anti-hypertensive compounds identified and/or isolated in the plants. CONCLUSIONS: This review suggests that medicinal plants possess varied therapeutic dynamics against hypertension and diabetes that could be exploited for the discovery of therapeutic preparation(s) or agent(s) for treating the two diseases.
ETHNOPHARMACOLOGICAL RELEVANCE: Diabetes and hypertension are pathophysiologically related diseases that co-exist with a wider complex of metabolic diseases having similar set of risk factors. There are numerous ethnopharmacological evidences on the anti-diabetic and/or anti-hypertensive properties of medicinal plants from various parts of the world, which are used as therapies to concomitantly manage diabetes and hypertension. AIM OF THE REVIEW: This article reviewed findings on medicinal plants with both anti-diabetic and anti-hypertensive effects reported in same experimental study to facilitate the development of dual-acting therapies against diabetes and hypertension. MATERIALS AND METHODS: A literature search was carried out on different scientific search engines including, but not limited to "PubMed", "Google Scholar", "Scopus" and ScienceDirect to identify published data in which plants in same experimental studies were reported to possess both anti-hyperglycemic and anti-hypertensive effects. Subsequently, the anti-diabetic/anti-hypertensive potency ratio (ψ) of the medicinal plants was computed. RESULTS: Sixty-four studies with 102 plant species matched the selection criteria. Members of the Fabaceae family were the most investigated plants, while the ψ greatly varied across the plants, with only 11 plants having a ψ ≃ 1. Withania somnifera Dunal was the only plant reported to show blood glucose-lowering and diuretic effects in humans, comparable to daonil. Caffeic acid, chlorogenic acid, caftaric acid, cichoric acid, verbascoside, leucosceptoside A, isoacteoside, fucoxanthin and nicotinamide were the reported dual acting anti-diabetic and anti-hypertensive compounds identified and/or isolated in the plants. CONCLUSIONS: This review suggests that medicinal plants possess varied therapeutic dynamics against hypertension and diabetes that could be exploited for the discovery of therapeutic preparation(s) or agent(s) for treating the two diseases.
Authors: Tatiana V Kirichenko; Vasily N Sukhorukov; Alexander M Markin; Nikita G Nikiforov; Ping-Yen Liu; Igor A Sobenin; Vadim V Tarasov; Alexander N Orekhov; Gjumrakch Aliev Journal: Front Pharmacol Date: 2020-04-08 Impact factor: 5.810
Authors: Tamaeh Monteiro-Alfredo; Paulo Matafome; Bianca Pancoti Iacia; Kátia Ávila Antunes; Jéssica Maurino Dos Santos; Janielle da Silva Melo da Cunha; Sara Oliveira; Alex Santos Oliveira; Jaqueline Ferreira Campos; Mariana Magalhães; Célia Cabral; Raquel Seiça; Cláudia Andrea Lima Cardoso; Caio Fernando Ramalho de Oliveira; Edson Lucas Dos Santos; Kely de Picoli Souza Journal: Oxid Med Cell Longev Date: 2020-03-22 Impact factor: 6.543
Authors: Ochuko L Erukainure; Motlalepula G Matsabisa; Veronica F Salau; Sunday O Oyedemi; Omolola R Oyenihi; Collins U Ibeji; Md Shahidul Islam Journal: Front Pharmacol Date: 2021-12-21 Impact factor: 5.810